COMBINED THERAPY USING SUBSTITUTED OXAZOLIDINONES

FIELD: organic chemistry, medicine, pharmacology. ^ SUBSTANCE: invention relates to a combination used in prophylaxis and/or treatment of thromboembolic diseases. Combination comprises N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-5-chloro-2-thiophene carboxamide of th...

Full description

Saved in:
Bibliographic Details
Main Authors PERNERSHTORFER DZHOZEF, SHLEMMER KARL-KHAJNTS, LAMPE TOMAS, POL'MANN JENS, PERTSBORN EHLIZABET, RERIG SJUZANNE, SHTRAUB ALEKSANDER
Format Patent
LanguageEnglish
Russian
Published 27.03.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:FIELD: organic chemistry, medicine, pharmacology. ^ SUBSTANCE: invention relates to a combination used in prophylaxis and/or treatment of thromboembolic diseases. Combination comprises N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-5-chloro-2-thiophene carboxamide of the formula (I): its pharmaceutically acceptable salts, hydrates or their mixtures and platelet aggregation inhibitor taken in subtherapeutic effective doses. Also, invention relates to a method for preparing this combination and a drug based on thereof. Proposed combination possesses the enhanced effectiveness. ^ EFFECT: improved and valuable medicinal properties of combination. ^ 4 cl, 2 tbl, 176 ex
Bibliography:Application Number: RU20040101404